Literature DB >> 31934109

Small-cell lung cancer with Mallory-Weiss syndrome as the prominent manifestation.

Fengzhu Guo1, Jiantao Wang1, Kuncheng Liu2, Zhen Zeng1, Feng Luo1.   

Abstract

The presence of Mallory-Weiss syndrome (MWS) in patients with small-cell lung cancer (SCLC) is uncommon. MWS is characterized by longitudinal superficial mucosal laceration at the esophagogastric junction and can be caused by a variety of causes, with upper digestive tract hemorrhage as the primary manifestation. SCLC is the most invasive histological subtype of lung cancer, and approximately a quarter of all SCLC patients undergo paraneoplastic syndrome of inappropriate antidiuretic hormone secretion, such as hyponatremia. In this study, we report a case of MWS in a middle-aged patient who was diagnosed with SCLC associated with hyponatremia. Clinicians should be alerted of the presence of MWS in upper gastrointestinal bleeding, such as epigastric pain, hematemesis, or melena, and keep SCLC in mind as a potential cause for underlying disease identification. IJCEP
Copyright © 2019.

Entities:  

Keywords:  Mallory-Weiss syndrome; hyponatremia; paraneoplastic syndromes; small-cell lung cancer

Year:  2019        PMID: 31934109      PMCID: PMC6949582     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  Overview of Mallory-Weiss syndrome.

Authors:  Kathleen Rich
Journal:  J Vasc Nurs       Date:  2018-06

2.  Mallory-Weiss tear. A complication of cancer chemotherapy.

Authors:  M L Fishman; M P Thirlwell; D S Daly
Journal:  Cancer       Date:  1983-12-01       Impact factor: 6.860

3.  Mallory-Weiss syndrome secondary to cis-platinum chemotherapy: an unusual complication.

Authors:  S Lubicz; M Shafir; S Diamond; R Monosan; C Cohen
Journal:  J Surg Oncol       Date:  1982-08       Impact factor: 3.454

4.  Mallory-Weiss tear: predisposing factors and predictors of a complicated course.

Authors:  D Y Kortas; L S Haas; W G Simpson; N J Nickl; L K Gates
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

5.  Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases.

Authors:  Keiko Kai; Naoto Tominaga; Kenichiro Koitabashi; Daisuke Ichikawa; Yugo Shibagaki
Journal:  CEN Case Rep       Date:  2019-01-14

6.  Mallory-Weiss syndrome. A study of 224 patients.

Authors:  C Sugawa; D Benishek; A J Walt
Journal:  Am J Surg       Date:  1983-01       Impact factor: 2.565

Review 7.  When is surgery indicated for small-cell lung cancer?

Authors:  Giulia Veronesi; Edoardo Bottoni; Giovanna Finocchiaro; Marco Alloisio
Journal:  Lung Cancer       Date:  2015-10-17       Impact factor: 5.705

8.  Outcomes of Propofol Sedation During Emergency Endoscopy Performed for Upper Gastrointestinal Bleeding.

Authors:  Chan Hyuk Park; Dong Soo Han; Jae Yoon Jeong; Chang Soo Eun; Kyo-Sang Yoo; Yong Cheol Jeon; Joo Hyun Sohn
Journal:  Dig Dis Sci       Date:  2015-11-05       Impact factor: 3.199

9.  Mallory-Weise syndrome in a patient treated with EGFR-TKI.

Authors:  Shinichiro Okauchi; Hiroko Watanabe; Gen Ohara; Hiroaki Satoh
Journal:  J Gen Fam Med       Date:  2017-06-21

10.  A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.

Authors:  Claudia Petereit; Okan Zaba; Ishak Teber; Heike Lüders; Christian Grohé
Journal:  BMC Pulm Med       Date:  2013-08-29       Impact factor: 3.317

View more
  1 in total

1.  Adenocarcinoma of the Gastroesophageal Junction Masquerading as Mallory-Weiss Syndrome.

Authors:  Takeshi Okamoto; Katsuyuki Fukuda
Journal:  Case Rep Gastroenterol       Date:  2022-01-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.